SHINGRIX Vaccine

SHINGRIX is a vaccine that is a recombinant and adjuvated and is used in the prevention of herpes zoster (shingles) and its complications, including post-herpetic neuralgia (PHN). It provokes a robust and sustained immune reaction and is prescribed particularly in older adults and those with a predisposition to shingles.

Composition (Single Dose of SHINGRIX)

Each dose contains:

• Recombinant Varicella Zoster Virus Glycoprotein E (Antigen) – 1 vial

• AS01B Adjuvant Suspension (Adjuvant) – 1 vial

Manufacturer

GlaxoSmithKline (GSK)

Vaccine Type

Recombinant, Adjuvanted Vaccine

Storage Instructions

• Store at 2°C to 8°C

• Do not freeze

Dosage & Schedule

• Two-dose schedule

• Second dose given 2 to 6 months after the first dose

• Administered only by a healthcare professional